戻る
「早戻しボタン」を押すと検索画面に戻ります。 [閉じる]

コーパス検索結果 (１語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します
1 ilus influenzae, and Neisseria meningitidis (meningococcus).
2 ogenicity against diverse strains of group B meningococcus.
3 st Haemophilus influenzae, pneumococcus, and meningococcus.
4 d resistance to innate immune killing in the meningococcus.
5 at KdtA is not essential for survival of the meningococcus.
6 the identification of virulence genes in the meningococcus.
7  in response to environmental stimuli in the meningococcus.
8  causing meningitis in most countries is the meningococcus.
9 e may be associated with transmission of the meningococcus.
10 l for many bacterial pathogens including the meningococcus.
11  antibody activity against a NadA-expressing meningococcus.
12  is largely restricted to the gonococcus and meningococcus.
13 was pneumococcus (46.4%: 71/153) followed by meningococcus (34.6%: 53/153) and H. influenzae (19.0%:
14 followed by H. influenzae (23.5%: 23/98) and meningococcus (9.2%: 9/98).
15  survival in the human nasopharynx makes the meningococcus a highly successful commensal bacterium.
16 eisseriae share with Neisseria meningitidis (meningococcus) a tendency towards overproduction of the
17      The bacterium is closely related to the meningococcus, a leading cause of bacterial meningitis.
18                                              Meningococcus, an obligate human bacterial pathogen, rem
19                    The majority of serotyped meningococcus and H. influenzae belonged to meningococcu
20                                 The Scottish Meningococcus and Pneumococcus Reference Laboratory (SMP
21 o the emergence of PCD in the gonococcus and meningococcus and potentially to the appearance of invas
22 develop an effective vaccine against group B meningococcus and to get these highly effective vaccines
23 niae (pneumococcus), Neisseria meningitidis (meningococcus), and Haemophilus influenzae are major cau
24 niae (pneumococcus), Neisseria meningitidis (meningococcus), and Haemophilus influenzae was performed
25 niae (pneumococcus), Neisseria meningitidis (meningococcus), and Haemophilus influenzae, at a sentine
26 erminator of sodC in Neisseria meningitidis (meningococcus), and sequence analysis strongly suggests
27  will help to combat the threat posed by the meningococcus, and accelerate the elimination of IMD.
28                                Pneumococcus, meningococcus, and H. influenzae accounted for 52.2%, 31
29        Phenotypic detection of pneumococcus, meningococcus, and H. influenzae was confirmed through m
30 rmed to detect the presence of pneumococcus, meningococcus, and H. influenzae.
31                                Pneumococcus, meningococcus, and Haemophilus influenzae cause a simila
32 ficity of the interaction between fH and the meningococcus, and informs attempts to develop novel the
33 development of a vaccine against serogroup B meningococcus, and it is now being used for several othe
34 veillance data, predict when lineages of the meningococcus are likely to become a public health conce
35 ne failures into successful vaccines against meningococcus B and respiratory syncytial virus (RSV).
36                              The 4 component meningococcus B vaccine (4CMenB) vaccine is the first va
37 ens included in Bexsero, the vaccine against Meningococcus B, for prevention from this devastating di
38 d by a common ancestor of the gonococcus and meningococcus but inactivated in the gonococcus on speci
39 nce could offer an adaptive advantage to the meningococcus during co-infection with other pathogens,
40 lammation) acts as a 'danger signal' for the meningococcus, enhancing its defence against human immun
41           The Meningitis Research Foundation Meningococcus Genome Library (MRF-MGL) exploits whole-ge
42                                A 4-component meningococcus group B vaccine (4CMenB) is the only vacci
43 especially for diverse organisms such as the meningococcus, has implications for public health interv
44 .5%) patients, pneumococcus in 8 (2.4%), and meningococcus in 2 (0.6%).
45 olysaccharide and conjugate vaccines against meningococcus in healthy adults, in the broader context
46 ified 174 significantly upregulated genes in meningococcus-infected blood: six encoded proteins that
47  protein factor H (fH) to the surface of the meningococcus is important for survival of the organism
48                                 However, the meningococcus is primarily an obligate commensal of the
49                  Neisseria meningitidis (the meningococcus) is a major human pathogen with a history
50                      Neisseria meningitidis (meningococcus) is a symbiont of the human nasopharynx.
51 roduced in the background of an unsialylated meningococcus itself bound small amounts of factor H, su
52                      Neisseria meningitidis (meningococcus [MC]) is able to enter and replicate withi
53                             Capsular group B meningococcus (MenB) remains an important cause of disea
54 cently licensed vaccines against serogroup B meningococcus (MenB).
55 ctored vaccine platform for capsular group B meningococcus (MenB).
56 ion on receptor recognition, adhesion of the meningococcus on nonhuman cells expressing human CD147 r
57            New vaccines that protect against meningococcus, pertussis and rotavirus are safe, effecti
58 od 1977-2018 were identified by the national meningococcus reference laboratory.
59                     Whereas most isolates of meningococcus remain penicillin-susceptible, fluoroquino
60  to SacB, the putative capsule polymerase of meningococcus serogroup A, suggesting that it plays a ro
61 spects were boosted by reports that licensed meningococcus serogroup B (MenB) vaccines provided parti
62  meningococcus and H. influenzae belonged to meningococcus serogroup W (45.5%) and H. influenzae type
63          Three open reading frames unique to meningococcus serogroup X were identified.
64               Neonatal mice were primed with meningococcus serotype C (MenC) conjugate MenC-CRM(197)+
65  that the PhoP homologue plays a role in the meningococcus similar to the role played by PhoP in salm
66 y of 42 subjects demonstrated an increase in meningococcus-specific intranasal immunoglobulin A (IgA)
67 oster, hepatitis B, influenza, pneumococcus, meningococcus, tetanus-diphtheria-pertussis, and human p
68                                       In the meningococcus, they have been used to define invasive ge
69 Neisseria gonorrhoeae, has been shown in the meningococcus to control indirectly, in response to iron
70 PhoP homologue playing a similar role in the meningococcus to PhoP in salmonella and suggest that it
71       fHbp binds human fH, which enables the meningococcus to resist complement-mediated bacteriolysi
72 -regulated genes play in the response of the meningococcus to the host environment may provide new in
73 tococcus, Haemophilus influenzae type b, and meningococcus vaccines.
74 re vaccination, whereas only one serogroup A meningococcus was isolated in 5001 people living in the
75                       Pharyngeal carriage of meningococcus was significantly more frequent among men
76 ilus influenzae, and Neisseria meningitidis (meningococcus) was performed by rapid diagnostic tests,
77 doses, ELISA antibody levels against group C meningococcus were significantly higher in conjugate vac
78 zed a two-component regulatory system in the meningococcus with homology to the phoP-phoQ system in s